<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-antibodies-09-00020">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sandbulte</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Jimenez</surname>
    <given-names>G.S.</given-names>
   </name>
   <name>
    <surname>Boon</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>L.R.</given-names>
   </name>
   <name>
    <surname>Treanor</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Webby</surname>
    <given-names>R.J.</given-names>
   </name>
  </person-group>
  <article-title>Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans</article-title>
  <source>PLoS Med.</source>
  <year>2007</year>
  <volume>4</volume>
  <elocation-id>e59</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pmed.0040059</pub-id>
  <pub-id pub-id-type="pmid">17298168</pub-id>
 </element-citation>
</ref>
